In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Iwo Bohr Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Iwo
Last Name:Bohr
Title:Dr.
Affiliation:University of Newcastle upon Tyne
Department:Institute for Ageing and Health
Street Address 1:Westgate Road,
City:Newcastle upon Tyne
Zip/Postal Code:NE4 6BE
Country/Territory:United Kingdom
Phone:444 44 07
Fax:+44 191 444 44 02
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 25 March 2006]
View all comments by Iwo Bohr
Clinical Interests:
Alzheimer Disease, Parkinson Disease, Aging Process
Research Focus:
Neurobiology, Neurotransmission, A-beta PP/A-beta, Neuropathology
Work Sector(s):
University
Web Sites:
Professional: http://www.ncl.ac.uk/iah/staff/profile/bohr
Top Papers
1) Bohr Iwo J (2005) Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease Lipids Health Dis. 2005 Jun 10;4(1):13
http://www.lipidworld.com/content/4/1/13

2) Bohr I. (2004) Hypercholesterolemic diet applied to rat dams protects their offspring against cognitive deficits. Simulated neonatal anoxia model. Physiol Behav 82: 703-711.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15327920&query_hl=4
3) Bohr I.J., Ray M.A., McIntosh J.M., Chalon S., Guilloteau D., McKeith I.G., Perry R.H., Clementi F., Perry E.K., Court J.APiggott . M.A. (2004) Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [125I]-conotoxinMII in the striatum and thalamus. Exp Neurol 191/2 pp. 292-300 (February 2005)
http://authors.elsevier.com/sd/article/S001448860400398X

4) Ray M, Bohr I, J. McIntosh M., Ballard C, McKeith I, Chalon S,
Guilloteaud D, Perry R, Perry E., Court J.A., Piggott M. (2004)
Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies:[125I]-α-conotoxin MII binding in the thalamus and striatum. Neuroscience Letters 372 (2004) 220–225
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15542244&query_hl=6

What is the greatest void to date in our knowledge of Alzheimer's Disease?
- further elucidation of the role played by cholesterol in the brain, especially in relation to cholinergic projections
- elucidating mechanisms leading to the formation of neupathological hallmarks,
- relationship between both hallmarks
What are the top three papers (not yours) you have read recently?
1) Koudinov AR (2005) Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci 229-230: 233-240.

2) Lane RM, Farlow MR. (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res. 46: 949-68.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15716586

3)Heverin M, Meaney S, Lutjohann D, Diczfalusy U, Wahren J, Bjorkhem I. (2005) Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res. 46: 1047-52.
If resources were not limited, what research projects would you pursue?
biopysical studies aiming at elucididating relationship of plasmalemmal cholesterol with muscarinic and nicotinic receptors using magnetic resonanse and anisotropy of fluorescense.
What is your leading hypothesis?
"choleterol as a guardian of cholinergic transmission" as presnted in my papers included above.
What piece of missing evidence would help prove it?
There is already enough evidence in favour of it spread out amongst different studies, it would be however valuable to combine these different approaches (amyloid hypothesis, cholinergic theory and cholesterol in relation to both above) in one unifying project.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad